TOPICAL TREATMENT OF IMMUNE CHECKPOINT INHIBITOR INDUCED DIARRHOEA, COLITIS OR ENTEROCOLITIS USING ANTIBODIES AND FRAGMENTS THEREOF

The present invention relates to the therapeutic topical use of compositions containing antibody molecules or functional fragments or derivatives specific to tumour necrosis factor alpha (TNFa), for treating or preventing immune checkpoint (ICP) inhibitor-induced adverse events.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GERSTNER, Ortrud, BRAVO, Roberto, BRUNO, Cristina, VARUM, Felipe, FURRER, Esther Maria, SPLEISS, Johannes, NEDELJKOVIC PROTIC, Marijana
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the therapeutic topical use of compositions containing antibody molecules or functional fragments or derivatives specific to tumour necrosis factor alpha (TNFa), for treating or preventing immune checkpoint (ICP) inhibitor-induced adverse events.